China’s amino acids manufacturers are expanding their production and application scope to include a broader range of supplements and pharmaceuticals, but overcapacity and environmental pollution are continuously adding high pressure on the future development.
More evidence of the potential for sports nutrition firms to boost business in China has been highlighted by a new Mintel survey, which reveals that three in four (76%) urban Chinese consumers are now regularly taking part in sport and fitness activities....
New Zealand contract manufacturer Alaron is preparing to submit plans for a new facility at its Nelson site, after acquiring Pharmalink’s freeze-drying business.
Japanese supplier Kewpie has seen more than 60 products launched in the country using its hyaluron ingredient Hyabest, with a raft of products touting its beauty or joint pain benefits for the ageing population in the wake of more relaxed regulations.
Malaysia-headquartered supplier ExcelVite is forecasting considerable growth for its palm tocotrienol ingredient, EVNol SupraBio, after a new study revealed the novel pathway that promotes hair follicle regeneration.
Japan's omega-3 firms are poised to benefit from rising consumer demand from South East Asia and China, if they can continue to invest in new product and technological developments.
DuPont in Japan says it is striving to spur innovation in the supplement and functional food space for the ageing population by launching 11 ‘smart ageing’ concepts at this week’s HI Japan show.
The rise of sports nutrition, complex regulatory and sourcing issues, and the ongoing surge in cross border e-commerce is driving trade association membership in China, as more international firms begin to tap into opportunities in the country.
India’s dietary supplement market will expand at an estimated compound annual growth rate (CAGR) of almost 12% over the next four to five years, with tech start-ups driving overall interest in health and wellness.
Vitamin manufacturer Swisse is throwing its weight behind the Australian government’s efforts to curb the country’s $8bn food waste burden by converting more local by-products and unwanted produce into supplement ingredients.
According to analysts, the Japan supplement market is forecast to hit ¥1,181bn by 2021, rising at around 1% annually...but where could additional growth come from?
Singapore supermarket chain FairPrice has launched a house-brand low-cost infant formula range in the wake of consumer and government complaints about the rising cost of branded milk products.
Supplement and functional food firms looking to enter the Japanese market with new products tailored for the ageing population must overcome high levels of brand loyalty to stand any chance of success, according to one expert.
French dairy ingredient supplier Epi Ingredients (the dry division of dairy cooperative Laïta) plans to expand in Asia, with infant nutrition growth among its top targets.
German supplier Wacker hopes to strengthen its Asia nutrition and food offerings by opening an application lab in Shanghai next year, a little over 18 months after doing the same in Singapore.
Recent clinical findings on the sports nutrition and skincare benefits of astaxanthin, as well as new delivery systems for products aimed at older consumers, are helping fuel growth for AstaReal across the region, according to its Singapore president.
Supplement and food firms operating in China’s booming cross border e-commerce market have been buoyed by a year-long extension of the existing trade laws, which were due to be replaced on January 1.
DuPont is targeting innovation at both ends of the age spectrum as it seeks to meet the vast needs of Asia's ageing societies, while also helping infant formula firms overcome considerable pricing and regulatory challenges.
UK firm OptiBiotix has signed a deal with Taiwan-based probiotic research company Bened Biomedical, marking the former’s foray into the gut-brain axis area of microbiome research.
The 2020 Olympics, 2019 Rugby World Cup, and the ageing population are contributing to ‘huge demand’ for protein products across Japan's sports nutrition and functional food space.
Taiwanese supplement manufacturer Phermpep, which produces kefir-based finished products and ingredients for improved bone and heart health, will launch in its first international markets later this year.
Botanical ingredient and analytics firm ChromaDex has partnered with Hong Kong-based retailer AS Watson to launch its US-made dietary supplement TRU NIAGEN in Asia.
Chinese supplier Guilin Layn Natural Ingredients plans to capitalise on the growing prevalence of health-conscious consumers to bring its monk fruit-based sweetener to Japan and Europe.
Supplement and functional food firms must appeal to consumers’ emotions if they want new products to sell well in Asia's more developed nations, according to Frost & Sullivan’s Asia-Pacific director Natasha Telles D’Costa.
Supplement firms looking to set up shop in China should not buy into local businesses’ promises of guan xi (connections), and should be mindful that it could take up to four years of preparation to enter the market.
New players in the market and groundbreaking technology will lead to a wave of personalised nutrition innovation across Asia, according to a panel of experts at Vitafoods Asia.
Canadian supplement firm Jamieson Wellness is targeting expansion in Asia on the back of a successful IPO, with its CEO identifying Asia's rising affluence and ageing population as two reasons for optimism.
New Zealand supplement firm Anagenix has secured an exclusive supply deal with Boysenberries New Zealand Ltd (BNZL), the largest marketer of boysenberries worldwide.
Australian regulator the Therapeutic Goods Administration (TGA) has released a draft bill covering new supplement laws, including a third approval pathway for higher-level health claims.
Trade body Complementary Medicines Australia (CMA) is to host a delegation from the China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) at its annual conference next month, as the Aussie industry seeks to build...
Blackmores' net profits fell by 42% to A$58m for the last financial year and sales slipped by 3% to A$693m, amid a significant decline in sales to Chinese consumers through Australian retailers.
The ever-growing importance of e-commerce sales for supplements in APAC was underlined in our first state of the industry survey, with almost 70% of respondents believing the channel will ultimately become as important as brick-and-mortar retail.
The failure to register intellectual property (IP) rights on time is a common problem for foreign supplement and functional food companies in China, according to global co-head of CMS Life Sciences Sector Group Nick Beckett.
The raft of new supplement and functional food regulations introduced in the past two years, or those imminently pending, have been broadly welcomed by the industry in APAC, according to the findings of our inaugural State of the Supplements, Health &...
Blackmores chairman Stephen Chapman announced today the appointment of Richard Henfrey as the company’s new CEO, following the resignation of former CEO Christine Holgate.
Health product manufacturer TSI Group has announced the approval of the first ever China Food and Drug Administration (CFDA) Manufacturing Licence for β-hydroxy β-methylbutyrate (HMB) production in China.
Dutch multinational firm Royal DSM has announced two new appointments to its APAC team: effective 1 September, Pieter Nuboer will be the Asia-Pacific VP of Animal Nutrition & Health, while André Rhoen will be the Asia-Pacific VP of Human Nutrition...
Three out of four respondents in the first NutraIngredients-Asia State of the Supplements, Health & Nutrition Survey believe their firms will post better financial results this year than last.
China’s Food and Drug Administration (CFDA) has announced the second batch of infant nutrition companies and products that have been approved under its new registration programme.
Network marketing company Nature’s Sunshine reported disappointing earnings yesterday, driven mostly by a protracted and difficult software switchover, according to management.
From trademark squatters to distributor disputes, there are a number of key threats that new entrants to China’s rocketing supplements market need to be aware of, according to a new report.
China’s Food and Drug Administration (CFDA) has announced the first wave of infant nutrition companies and products that have passed its new registration programme, and are now free to trade in the country from January 1, 2018.
The Asia-Pacific beta-glucan market will increase from US$65.21 million to $109.54 million by 2022 due to soaring demand for nutraceuticals and functional foods, according to analysts.
An internal investigation into business practices in China has taken some of the air out of the balloon of Usana Health Sciences, as the company’s stock price declined after an earnings report that was lower than analysts’ estimates. And a launch of a...
Singapore’s government enterprise body SPRING is joining forces with economic development agency Primary Industries and Regions South Australia (PIRSA) to collaborate on functional food innovation.
